| P2093 | author name string | Summer F Acevedo | |
| | Diana Morales | |
| | Efthimios C M Skoulakis | |
| P2860 | cites work | Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1 | Q22011109 |
| | 14-3-3zeta is an effector of tau protein phosphorylation | Q22254233 |
| | HIV-1 gp120- and gp160-induced apoptosis in cultured endothelial cells is mediated by caspases | Q24273423 |
| | Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3 | Q24532106 |
| | Increased levels of epsilon and gamma isoforms of 14-3-3 proteins in cerebrospinal fluid in patients with Creutzfeldt-Jakob disease | Q24548866 |
| | Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression | Q24606745 |
| | HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection | Q24608690 |
| | Direct interaction between protein kinase C theta (PKC theta) and 14-3-3 tau in T cells: 14-3-3 overexpression results in inhibition of PKC theta translocation and function | Q24648178 |
| | Human immunodeficiency virus vpr product is a virion-associated regulatory protein | Q24649600 |
| | Two orphan seven-transmembrane segment receptors which are expressed in CD4-positive cells support simian immunodeficiency virus infection | Q24652969 |
| | Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity | Q24685633 |
| | Human CNS cultures exposed to HIV-1 gp120 reproduce dendritic injuries of HIV-1-associated dementia | Q24794489 |
| | Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding | Q27619633 |
| | Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways | Q27729753 |
| | 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation | Q28144100 |
| | 14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome | Q28178021 |
| | The HIV Env-mediated fusion reaction | Q28188544 |
| | Role of 14-3-3epsilon, c-Myc/Max, and Akt phosphorylation in HIV-1 gp 120-induced mesangial cell proliferation | Q28201539 |
| | Laboratory diagnosis of central nervous system infections | Q28214852 |
| | HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25 | Q28214929 |
| | 14-3-3 proteins in neurodegeneration | Q28248108 |
| | Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel | Q28257691 |
| | Partner molecules of accessory protein Vpr of the human immunodeficiency virus type 1 | Q28261598 |
| | New perspectives on PKCtheta, a member of the novel subfamily of protein kinase C | Q28272987 |
| | HIV and antiretroviral therapy in the brain: neuronal injury and repair | Q28279808 |
| | The HIV nef protein associates with protein kinase C theta | Q28282007 |
| | Neuronal migration disorders: clinical, neuroradiologic and genetics aspects | Q28305616 |
| | Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease | Q28366081 |
| | Importance of the nef gene for maintenance of high virus loads and for development of AIDS | Q29618369 |
| | 14-3-3 proteins: structure, function, and regulation | Q29619100 |
| | HIV-1 accessory proteins--ensuring viral survival in a hostile environment | Q29619538 |
| | Modulation of HIV-1-host interaction: role of the Vpu accessory protein | Q30397761 |
| | How to improve the clinical diagnosis of Creutzfeldt-Jakob disease | Q30584961 |
| | 14-3-3 Protein isoforms and atypical patterns of the 14-3-3 assay in the diagnosis of Creutzfeldt-Jakob disease | Q43890002 |
| | 14-3-3 Protein in the cerebrospinal fluid of patients with acute transverse myelitis and multiple sclerosis. | Q44001192 |
| | Cleavage of 14-3-3 protein by caspase-3 facilitates bad interaction with Bcl-x(L) during apoptosis | Q44376516 |
| | Specification of 14-3-3 proteins in Lewy bodies | Q44499897 |
| | 14-3-3 protein in the CSF of patients with rapidly progressive dementia | Q44545771 |
| | HIV-1 accessory protein Vpr inhibits the effect of insulin on the Foxo subfamily of forkhead transcription factors by interfering with their binding to 14-3-3 proteins: potential clinical implications regarding the insulin resistance of HIV-1-infect | Q45199116 |
| | Human immunodeficiency virus type 1 gp120-mediated disruption of tight junction proteins by induction of proteasome-mediated degradation of zonula occludens-1 and -2 in human brain microvascular endothelial cells | Q45394269 |
| | Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection | Q45738786 |
| | Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG. | Q47767870 |
| | Molecular evolution of the 14-3-3 protein family | Q48059858 |
| | Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes | Q48207122 |
| | Genomic copy number variations at 17p13.3 and epileptogenesis | Q48273584 |
| | Deletion of YWHAE in a patient with periventricular heterotopias and pronounced corpus callosum hypoplasia | Q48503149 |
| | Wernicke encephalopathy and Creutzfeldt-Jakob disease | Q48719898 |
| | Molecular cloning of cDNA to rat 14-3-3 η chain polypeptide and the neuronal expression of the mRNA in the central nervous system | Q48737237 |
| | The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies | Q48913771 |
| | No association of the YWHAE gene with schizophrenia, major depressive disorder or bipolar disorder in the Han Chinese population | Q48942800 |
| | Human 14-3-3 protein: radioimmunoassay, tissue distribution, and cerebrospinal fluid levels in patients with neurological disorders | Q48949632 |
| | Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders | Q49085019 |
| | Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. | Q50782335 |
| | A new 17p13.3 microduplication including the PAFAH1B1 and YWHAE genes resulting from an unbalanced X;17 translocation. | Q51821429 |
| | Deletion of 14-3-3{varepsilon} and CRK: a clinical syndrome with macrocephaly, developmental delay, and generalized epilepsy. | Q51900044 |
| | Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. | Q52209534 |
| | Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. | Q53231720 |
| | HCV core protein promotes heparin binding EGF-like growth factor expression and activates Akt. | Q53260500 |
| | The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease. | Q53292933 |
| | Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease. | Q53888877 |
| | Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. | Q54188872 |
| | Current clinical diagnosis in Creutzfeldt-Jakob disease: Identification of uncommon variants | Q57274037 |
| | Cerebrospinal fluid biomarkers in clinically isolated syndromes and multiple sclerosis | Q59505826 |
| | Diagnostic value of CSF 14-3-3 detection in sporadic CJD diagnosis according to the age of the patient | Q62381832 |
| | Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120 | Q67572030 |
| | Exposure to gp120 of HIV‐1 Induces an Increased Release of Arachidonic Acid in Rat Primary Neuronal Cell Culture Followed by NMDA Receptor‐mediated Neurotoxicity | Q71795847 |
| | Subcellular localisation of 14-3-3 isoforms in rat brain using specific antibodies | Q72815795 |
| | Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates | Q73556100 |
| | 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis | Q73639546 |
| | Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease | Q74333080 |
| | Gatekeeper role of 14-3-3tau protein in HIV-1 gp120-mediated apoptosis of human endothelial cells by inactivation of Bad | Q80211870 |
| | HIV-1 Vpr induces G2 cell cycle arrest in fission yeast associated with Rad24/14-3-3-dependent, Chk1/Cds1-independent Wee1 upregulation | Q80250592 |
| | Genetic isolation of transport signals directing cell surface expression | Q81197748 |
| | Association of 14-3-3 epsilon gene haplotype with completed suicide in Japanese | Q81663512 |
| | 14-3-3 protein detection and sporadic CJD: the status quo serves well while awaiting progress | Q82035266 |
| | HIV/hepatitis C coinfection natural history and disease progression | Q35801431 |
| | Pharmacological chaperones: potential treatment for conformational diseases. | Q35820522 |
| | K2P channels and their protein partners. | Q36142862 |
| | 14-3-3 proteins: regulators of numerous eukaryotic proteins | Q36276386 |
| | Regulation of neural cell survival by HIV-1 infection. | Q36317663 |
| | 14-3-3 proteins: a historic overview | Q36470005 |
| | 14-3-3 theta binding to cell cycle regulatory factors is enhanced by HIV-1 Vpr | Q36665575 |
| | Host factors exploited by retroviruses | Q36746350 |
| | Evolution of HIV dementia with HIV infection | Q37073653 |
| | Mechanisms of HIV-1 Nef function and intracellular signaling | Q37183848 |
| | Enhancement of the surface expression of G protein-coupled receptors. | Q37316198 |
| | Apoptosis induced by HIV-1 infection of the central nervous system | Q37360984 |
| | Anti-apoptotic actions of PPAR-gamma against ischemic stroke | Q37686356 |
| | The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review | Q37790529 |
| | Trafficking of neuronal two pore domain potassium channels | Q37848077 |
| | Structural basis of 14-3-3 protein functions. | Q37932715 |
| | G protein-coupled receptors in HIV and SIV entry: new perspectives on lentivirus-host interactions and on the utility of animal models | Q39543389 |
| | Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest | Q39880367 |
| | HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration. | Q40149510 |
| | Interaction of HCV core protein with 14-3-3epsilon protein releases Bax to activate apoptosis | Q40201962 |
| | Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. | Q40717934 |
| | 14-3-3 proteins: biological function and domain structure | Q40949003 |
| | HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo | Q41071784 |
| | Phosphorylation-dependent C-terminal binding of 14-3-3 proteins promotes cell surface expression of HIV co-receptor GPR15. | Q41955759 |
| | 14-3-3 protein in CSF: an early predictor of SIV CNS disease | Q42476359 |
| | Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. | Q43038781 |
| | Detection of 14-3-3 brain protein in cerebrospinal fluid of HIV infected patients | Q43062342 |
| | Increased concentrations of 14-3-3 epsilon, gamma and zeta isoforms in cerebrospinal fluid of AIDS patients with neuronal destruction | Q43753321 |
| | Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain | Q43850058 |
| | Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease | Q43863115 |
| | Increased LIS1 expression affects human and mouse brain development | Q30639738 |
| | Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests | Q30698122 |
| | 14-3-3 proteins in the nervous system | Q33188355 |
| | HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase | Q33290831 |
| | Binding of 14-3-3beta to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population | Q33292199 |
| | Synaptic proteins linked to HIV-1 infection and immunoproteasome induction: proteomic analysis of human synaptosomes | Q33495226 |
| | Neuronal number and volume alterations in the neocortex of HIV infected individuals. | Q33591126 |
| | Pathogenesis of HIV in the central nervous system | Q33781978 |
| | Patterns of CCR5, CXCR4, and CCR3 usage by envelope glycoproteins from human immunodeficiency virus type 1 primary isolates. | Q33782930 |
| | Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation | Q33801078 |
| | Vpr protein of human immunodeficiency virus type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: implications for cell cycle arrest | Q33834244 |
| | Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease | Q33933305 |
| | Sequencing of DISC1 pathway genes reveals increased burden of rare missense variants in schizophrenia patients from a northern Swedish population. | Q33997189 |
| | Neurocognitive impairment and HIV risk factors: a reciprocal relationship | Q34005620 |
| | How do 14-3-3 proteins work?-- Gatekeeper phosphorylation and the molecular anvil hypothesis | Q34120299 |
| | 14-3-3 proteins: regulation of subcellular localization by molecular interference | Q34127838 |
| | Identification of a protein encoded by the vpu gene of HIV-1. | Q34163678 |
| | Identification of HIV-1 vpr product and function | Q34168026 |
| | Biochemical mechanism of HIV-I Vpr function. Specific interaction with a cellular protein. | Q34341976 |
| | Specificity of 14-3-3 isoform dimer interactions and phosphorylation | Q34797095 |
| | Specific 14-3-3 isoform detection and immunolocalization in prion diseases | Q34797160 |
| | HIV-1 accessory protein Vpr: relevance in the pathogenesis of HIV and potential for therapeutic intervention | Q34957142 |
| | Hippocampal dysregulation of synaptic plasticity-associated proteins with age-related cognitive decline | Q34988032 |
| | PI3K/Akt signalling-mediated protein surface expression sensed by 14-3-3 interacting motif | Q34993298 |
| | The dynamics of cell cycle regulation. | Q35007334 |
| | Human immunodeficiency virus-associated dementia: an evolving disease | Q35112016 |
| | Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier. | Q35114694 |
| | The 14-3-3 proteins: gene, gene expression, and function | Q35166332 |
| | Miller-Dieker syndrome: analysis of a human contiguous gene syndrome in the mouse | Q35194904 |
| | Models of neuronal injury in AIDS: another role for the NMDA receptor? | Q35315325 |
| | Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease | Q35462665 |
| | The role of specific isoforms of 14-3-3 protein in regulating protein kinase activity in the brain | Q35491257 |
| | 14-3-3 proteins: a highly conserved, widespread family of eukaryotic proteins | Q35624026 |
| P433 | issue | 5 | |
| P921 | main subject | biomarker | Q864574 |
| | neurodegeneration | Q1755122 |
| P304 | page(s) | 341-353 | |
| P577 | publication date | 2012-07-19 | |
| P1433 | published in | Journal of NeuroVirology | Q6295640 |
| P1476 | title | 14-3-3s are potential biomarkers for HIV-related neurodegeneration | |
| P478 | volume | 18 | |